InvestorsHub Logo

hoffmann6383

08/24/22 12:31 PM

#507878 RE: iclight #507877

LOL, complete bullshit. The MHRA disagrees as they just designed 2 pediatric trials using the same ECA methodology as was used in the DCVax-L adult trial.

StonkMaster

08/24/22 12:37 PM

#507879 RE: iclight #507877

This is comical

LearningEveryTrade

08/24/22 12:47 PM

#507881 RE: iclight #507877

Ace disagrees and thinks LP and her Global Force are doing great dealing with the adversity of running a trial amid new discoveries about pseudo progression.

sukus

08/24/22 1:16 PM

#507885 RE: iclight #507877

You are totally wrong iclight. I believe the other way around. This time NWBO needs Sawston/Advent to progress to meet objectives to bring treatment to patients. They are the workhorse if you will to get to the destination. Why selling the workhorse? If NWBO wanted to meet its objectives, keep the workhorse ready and happy.